OUNDLE — All Prescriptions & Medications — Page 11
Practice Code: K83023 | PETERBOROUGH, PE8 4JA
Showing results 501-550 of 622
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 18 | 840 | £1.8K | +64.5% ▲ | |
| Ins degludec/liraglutide | 17 | 79 | £2.4K | +5.7% ▲ |
| Mercaptopurine | 17 | 588 | £283 | +9.8% ▲ |
| Hydroxycarbamide | 17 | 476 | £72 | -41.1% ▼ |
| Other calcium supplement preparations | 17 | 630 | £282 | +126.7% ▲ |
| Sevelamer | 17 | 1,572 | £231 | -22.4% ▼ |
| Chlorhexidine gluconate | 17 | 7,250 | £122 | -42.4% ▼ |
| 17 | 255 | £76 | -41.3% ▼ | |
| 17 | 1,260 | £679 | +10.4% ▲ | |
| 17 | 550 | £380 | +63.4% ▲ | |
| 17 | 790 | £4.9K | +94.3% ▲ | |
| 17 | 480 | £3.1K | +33.1% ▲ | |
| Chlorphenamine maleate | 16 | 1,892 | £52 | -85.5% ▼ |
| Entacapone | 16 | 1,650 | £372 | +5.0% ▲ |
| Betamethasone sodium phosphate | 16 | 1,044 | £137 | +30.1% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 16 | 48.5K | £820 | -58.1% ▼ |
| Betamethasone sodium phosphate | 16 | 160 | £35 | -38.2% ▼ |
| Other sunscreening preparations | 16 | 2,000 | £152 | +104.2% ▲ |
| 16 | 41 | £451 | +22.4% ▲ | |
| 16 | 1,620 | £2.4K | +145.9% ▲ | |
| Sodium cromoglicate | 15 | 3,048 | £4.5K | +45.0% ▲ |
| Zinc oxide | 15 | 309 | £40 | -27.5% ▼ |
| Bempedoic acid/Ezetimibe | 15 | 420 | £746 | -75.4% ▼ |
| Imipramine hydrochloride | 15 | 588 | £21 | -41.2% ▼ |
| Atomoxetine hydrochloride | 15 | 420 | £937 | -55.6% ▼ |
| Prasterone | 15 | 420 | £227 | +127.3% ▲ |
| Etonogestrel | 15 | 15 | £1.2K | -48.1% ▼ |
| Sodium zirconium cyclosilicate | 15 | 426 | £2.0K | +70.8% ▲ |
| Dantrolene sodium | 15 | 3,180 | £495 | -16.8% ▼ |
| Nepafenac | 15 | 75 | £213 | +141.5% ▲ |
| Pimecrolimus | 15 | 660 | £399 | -11.4% ▼ |
| Cilostazol | 14 | 784 | £494 | +0.9% vs avg |
| INR blood testing reagents | 14 | 576 | £1.6K | +85.8% ▲ |
| Amisulpride | 14 | 856 | £302 | -80.1% ▼ |
| Trifluoperazine | 14 | 784 | £395 | -7.2% ▼ |
| Valproic acid | 14 | 840 | £303 | -83.9% ▼ |
| Flupentixol hydrochloride | 14 | 420 | £34 | -57.3% ▼ |
| Midazolam hydrochloride | 14 | 45 | £997 | -2.9% ▼ |
| Riluzole | 14 | 700 | £3.6K | +34.9% ▲ |
| Cefixime | 14 | 1,568 | £2.8K | +642.2% ▲ |
| Cyproterone acetate | 14 | 784 | £1.2K | +27.5% ▲ |
| Mefenamic acid | 14 | 379 | £70 | -69.0% ▼ |
| Acetazolamide | 14 | 1,568 | £65 | -35.4% ▼ |
| Other individually formulated bought in preparations | 14 | 1,137 | £336 | -57.1% ▼ |
| 14 | 14 | £32 | -56.8% ▼ | |
| 14 | 64 | £168 | +3.1% ▲ | |
| 14 | 1,200 | £449 | +5.4% ▲ | |
| 14 | 29 | £215 | +125.8% ▲ | |
| 14 | 1,260 | £3.3K | +59.3% ▲ | |
| 14 | 630 | £3.0K | +18.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.